Vaxcyte, Inc.PCVXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank52
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P52
Within normal range
vs 5Y Ago
-1.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-13.16%
Q3 2025-7.14%
Q2 2025-25.13%
Q1 2025-11.48%
Q4 2024-15.90%
Q3 20248.54%
Q2 2024-33.64%
Q1 202441.80%
Q4 2023-74.01%
Q3 2023-29.70%
Q2 2023-22.41%
Q1 202317.77%
Q4 2022-47.79%
Q3 2022-22.33%
Q2 2022-22.09%
Q1 2022-31.41%
Q4 2021-10.74%
Q3 2021-13.57%
Q2 2021-2.54%
Q1 2021-18.97%
Q4 20208.71%
Q3 2020-0.40%
Q2 202023.09%
Q1 2020-74.23%
Q4 2019-30.47%
Q3 20190.75%
Q2 201912.28%
Q1 20190.00%